Table 2.
Laboratory test results and echocardiographic and angiographic characteristics.
| Before PS match | After PS match | |||||
|---|---|---|---|---|---|---|
| β-Blocker (-) N = 1801 | β-Blocker (+) N = 3790 | P value | β-Blocker (-) N = 1786 | β-Blocker (+) N = 1786 | P value | |
| Laboratory values | ||||||
| WBC (×109/L) | 6.1 (5.2, 7.3) | 6.4 (5.4, 7.5) | <0.001 | 6.2 (5.2, 7.3) | 6.3 (5.3, 7.4) | 0.011 |
| Hemoglobin (g/L) | 135.6 ± 15.9 | 135.4 ± 16.8 | 0.648 | 135.6 ± 15.9 | 135.0 ± 17.3 | 0.245 |
| PLT (×1012/L) | 211.0 (179.0, 248.0) | 215.0 (180.0, 254.0) | 0.021 | 211.0 (179.0, 249.0) | 211.0 (177.0, 250.0) | 0.988 |
| HsCRP (mg/L) | 1.3 (0.6, 2.5) | 1.6 (0.7, 3.3) | <0.001 | 1.3 (0.6, 2.5) | 1.5 (0.6, 3.3) | 0.001 |
| FBG (mmol/l) | 5.8 (5.0, 7.5) | 6.1 (5.1, 8.0) | <0.001 | 5.8 (5.0, 7.5) | 5.9 (5.0, 7.7) | 0.432 |
| HbA1C (%) | 6.0 (5.6, 6.8) | 6.2 (5.7, 7.2) | <0.001 | 6.0 (5.6, 6.8) | 6.1 (5.6, 6.9) | 0.294 |
| ALT (U/L) | 17.0 (12.0, 24.0) | 18.0 (13.0, 26.0) | <0.001 | 17.0 (12.8, 24.0) | 17.0 (13.0, 25.0) | 0.211 |
| Creatinine (μmol/L) | 75.3 (64.9, 86.1) | 75.9 (65.5, 87.9) | 0.354 | 75.2 (64.9, 86.1) | 75.4 (65.5, 86.9) | 0.318 |
| eGFR (mL/min/1.73 m2) | 156.6 (124.1, 191.9) | 153.3 (122.6, 190.9) | 0.084 | 156.6 (124.0,192.0) | 155.0 (124.2,190.5) | 0.594 |
| TC (mmol/L) | 4.1 (3.5, 4.8) | 4.0 (3.4, 4.8) | 0.165 | 4.1 (3.5, 4.8) | 4.1 (3.4, 4.8) | 0.287 |
| TG (mmol/L) | 1.3 (1.0, 1.9) | 1.4 (1.0, 2.0) | <0.001 | 1.3 (1.0, 1.9) | 1.3 (1.0, 1.9) | 0.734 |
| HDL (mmol/L) | 1.1 (0.9, 1.3) | 1.1 (0.9, 1.2) | 0.197 | 1.1 (0.9, 1.3) | 1.1 (0.9, 1.2) | 0.978 |
| LDL (mmol/L) | 2.3 (1.8, 2.8) | 2.2 (1.8, 2.7) | 0.074 | 2.3 (1.8, 2.8) | 2.2 (1.8, 2.7) | 0.127 |
|
| ||||||
| Echocardiographic values | ||||||
| LA (cm) | 3.7 ± 0.4 | 3.7 ± 0.5 | 0.091 | 3.7 ± 0.4 | 3.7 ± 0.5 | 0.406 |
| LVEDD (cm) | 5.0 (4.7, 5.3) | 5.0 (4.7, 5.3) | 0.912 | 5.0 (4.7, 5.3) | 5.0 (4.7, 5.3) | 0.330 |
| LVESD (cm) | 3.1 (2.9, 3.4) | 3.1 (2.9, 3.4) | 0.076 | 3.1 (2.9, 3.4) | 3.1 (2.9, 3.4) | 0.086 |
| LVEF (%) | 0.67 (0.64, 0.71) | 0.67 (0.63, 0.70) | 0.026 | 0.67 (0.64, 0.71) | 0.67 (0.63, 0.70) | 0.129 |
| LVEF (40–49) (%) | 48 (2.7) | 186 (4.9) | <0.001 | 48 (2.7) | 69 (3.9) | 0.048 |
| LVEF (<40) (%) | 10 (0.6) | 58 (1.5) | <0.001 | 10 (0.6) | 24 (1.3) | 0.039 |
| LVFS (%) | 0.38 (0.35, 0.40) | 0.37 (0.34, 0.40) | 0.025 | 0.38 (0.35, 0.40) | 0.37 (0.35,0.40) | 0.138 |
|
| ||||||
| Angiography values | ||||||
| LM (%) | 164 (9.1) | 402 (10.6) | 0.082 | 161 (9.0) | 183 (10.2) | 0.212 |
| Multivessels (%) | 1379 (76.6) | 3155 (83.2) | <0.001 | 1368 (76.6) | 1446 (81.0) | 0.001 |
| CTO (%) | 140 (7.8) | 404 (10.7) | 0.001 | 140 (7.8) | 181 (10.1) | 0.016 |
| PCI (%) | 957 (53.1) | 2277 (60.1) | <0.001 | 950 (53.2) | 1087 (60.9) | <0.001 |
|
| ||||||
| Medication used at discharge | ||||||
| Antiplatelet agent (%) | 1670 (92.7) | 3727 (98.3) | <0.001 | 1657 (92.8) | 1757 (98.4) | <0.001 |
| ACEI/ARB (%) | 798 (44.3) | 1984 (52.3) | <0.001 | 796 (44.6) | 920 (51.5) | <0.001 |
| Statins (%) | 1582 (87.8) | 3508 (92.6) | <0.001 | 1570 (87.9) | 1672 (93.6) | <0.001 |
Data are presented as mean ± SD, IQR, or n (%). WBC, white blood cells; PLT, platelet count; hsCRP, hypersensitivity C-reactive protein; eGFR, estimated glomerular filtration rate; FBG, fasting blood glucose; HbAIC, glycosylated hemoglobin; ALT, alanine aminotransferase; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; LVEDD, left ventricular end-diastolic dimension; LVESD, left ventricular end-systolic dimension; LVEF, left ventricular ejection fraction; LVFS, left ventricular fraction shortening; LM, left main trunk; CTO, chronic total occlusions; PCI, percutaneous coronary intervention; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker.